Log in

NASDAQ:BKYIBIO-key International Stock Price, Forecast & News

-0.03 (-3.42 %)
(As of 08/13/2020 04:00 PM ET)
Today's Range
Now: $0.79
50-Day Range
MA: $0.76
52-Week Range
Now: $0.79
Volume7.47 million shs
Average Volume3.61 million shs
Market Capitalization$17.52 million
P/E RatioN/A
Dividend YieldN/A
BIO-key International, Inc. develops and markets fingerprint biometric identification and identity verification technologies, authentication-transaction security technologies, and related identity management and credentialing biometric hardware and software solutions. Its solutions enable application developers, value added resellers, and channel partners to integrate fingerprint biometrics into their applications. The company's products include Vector Segment Technology SDK, a biometric software development kit that provides developers the ability to incorporate its biometric capabilities into their respective product offerings or infrastructure; Intelligent Image Indexing, a biometric identification solution that offers one-to-many and one-to-one user identification; and Biometric Service Provider, which provides support for the BioAPI for a compliant interface to applications using biometrics for verification and identification. Its products also comprise ID Director, a solution for single sign on integration with CA Technologies SiteMinder, Oracle's Fusion Middleware SSO, IBM Tivoli Access Manager, and other solutions; and WEB-key, an authentication-transaction security technology to conduct identification and identity verification transactions in insecure environments, such as the world wide Web or off-site cloud environments. The company also sells third-party hardware components. BIO-key International, Inc. markets its products through its direct sales force, as well as through distributors, resellers, integrators, and partner networks to government and corporate customers primarily in North America. It has strategic partnership with Quantum Business Advisory to bring its software and hardware solutions to enterprises in India. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.70 out of 5 stars

Industry, Sector and Symbol

Industry Computer & office equipment
Current SymbolNASDAQ:BKYI



Sales & Book Value

Annual Sales$2.27 million
Book Value($0.16) per share


Net Income$-14,590,000.00
Net Margins-721.57%


Market Cap$17.52 million
Next Earnings Date8/14/2020 (Estimated)
OptionableNot Optionable
-0.03 (-3.42 %)
(As of 08/13/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BKYI News and Ratings via Email

Sign-up to receive the latest news and ratings for BKYI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

BIO-key International (NASDAQ:BKYI) Frequently Asked Questions

How has BIO-key International's stock been impacted by COVID-19?

BIO-key International's stock was trading at $1.18 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BKYI stock has decreased by 33.1% and is now trading at $0.79.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of BIO-key International?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BIO-key International in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for BIO-key International

When is BIO-key International's next earnings date?

BIO-key International is scheduled to release its next quarterly earnings announcement on Friday, August 14th 2020.
View our earnings forecast for BIO-key International

How were BIO-key International's earnings last quarter?

BIO-key International, Inc. (NASDAQ:BKYI) announced its quarterly earnings results on Monday, June, 8th. The technology company reported ($0.23) earnings per share (EPS) for the quarter. The technology company earned $0.52 million during the quarter. BIO-key International had a negative return on equity of 562.09% and a negative net margin of 721.57%.
View BIO-key International's earnings history

What price target have analysts set for BKYI?

1 equities research analysts have issued 12 month price targets for BIO-key International's stock. Their forecasts range from $2.00 to $2.00. On average, they expect BIO-key International's share price to reach $2.00 in the next year. This suggests a possible upside of 153.2% from the stock's current price.
View analysts' price targets for BIO-key International

Has BIO-key International been receiving favorable news coverage?

Media coverage about BKYI stock has been trending very negative this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. BIO-key International earned a media sentiment score of -3.2 on InfoTrie's scale. They also assigned news headlines about the technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term.
View the latest news about BIO-key International

Who are some of BIO-key International's key competitors?

What other stocks do shareholders of BIO-key International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BIO-key International investors own include Biocept (BIOC), Onconova Therapeutics (ONTX), Chesapeake Energy (CHKAQ), Chesapeake Energy (CHKAQ), Ibio (IBIO), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Co-Diagnostics (CODX), Digital Ally (DGLY) and Acasti Pharma (ACST).

Who are BIO-key International's key executives?

BIO-key International's management team includes the following people:
  • Mr. Michael W. DePasquale, Chairman & CEO (Age 64)
  • Ms. Cecilia C. Welch, Chief Financial Officer (Age 59)
  • Ms. Mira K. LaCous, Chief Technology Officer (Age 57)
  • Mr. Scott Mahnken, VP of Marketing (Age 59)
  • Mr. James Sullivan, Sr. VP of Strategy & Bus. Devel. (Age 52)

What is BIO-key International's stock symbol?

BIO-key International trades on the NASDAQ under the ticker symbol "BKYI."

How do I buy shares of BIO-key International?

Shares of BKYI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is BIO-key International's stock price today?

One share of BKYI stock can currently be purchased for approximately $0.79.

How big of a company is BIO-key International?

BIO-key International has a market capitalization of $17.52 million and generates $2.27 million in revenue each year. BIO-key International employs 18 workers across the globe.

What is BIO-key International's official website?

The official website for BIO-key International is www.bio-key.com.

How can I contact BIO-key International?

BIO-key International's mailing address is 3349 HIGHWAY 138 BUILDING A SUITE E, WALL NJ, 07719. The technology company can be reached via phone at 732-359-1100 or via email at [email protected]

This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.